128 related articles for article (PubMed ID: 34060966)
41. Screening for Down syndrome during the first and second trimesters: impact of risk estimation parameters.
Forest JC; Massé J; Rousseau F; Moutquin JM; Brideau NA; Bélanger M
Clin Biochem; 1995 Aug; 28(4):443-9. PubMed ID: 8521600
[TBL] [Abstract][Full Text] [Related]
42. Ethnic-specific reference range affects the efficacy of quadruple test as a universal screening for Down syndrome in a developing country.
Pranpanus S; Kor-Anantakul O; Suntharasaj T; Suwanrath C; Hanprasertpong T; Pruksanusak N; Petpichetchian C; Suksai M; Chainarong N; Sawaddisan R
PLoS One; 2021; 16(5):e0251381. PubMed ID: 33984018
[TBL] [Abstract][Full Text] [Related]
43. Maternal serum unconjugated oestriol and human chorionic gonadotrophin levels in pregnancies with insulin-dependent diabetes: implications for screening for Down's syndrome.
Wald NJ; Cuckle HS; Densem JW; Stone RB
Br J Obstet Gynaecol; 1992 Jan; 99(1):51-3. PubMed ID: 1372176
[TBL] [Abstract][Full Text] [Related]
44. Second-trimester maternal serum quadruple test for Down syndrome screening: a Taiwanese population-based study.
Shaw SW; Lin SY; Lin CH; Su YN; Cheng PJ; Lee CN; Chen CP
Taiwan J Obstet Gynecol; 2010 Mar; 49(1):30-4. PubMed ID: 20466289
[TBL] [Abstract][Full Text] [Related]
45. Evaluation of sporadic bovine alkaline phosphatase interference in the Beckman Access unconjugated estriol (uE3) assay affecting maternal serum screening results.
Bornhorst JA; Ramos PA; Sutterer ER; Herrli NM; Figdore DJ; Flieth TL; Ness KM; Fatica EM; Algeciras-Schimnich A
Clin Biochem; 2021 Jan; 87():93-99. PubMed ID: 33188774
[TBL] [Abstract][Full Text] [Related]
46. Evaluation of a dimeric inhibin-A assay for assessing fetal Down syndrome: establishment, comparison, and monitoring of median concentrations for normal pregnancies.
Erickson JA; Ashwood ER; Gin CA
Arch Pathol Lab Med; 2004 Apr; 128(4):415-20. PubMed ID: 15043467
[TBL] [Abstract][Full Text] [Related]
47. The usefulness of hCG and unconjugated oestriol in prenatal diagnosis of trisomy 18.
Leporrier N; Herrou M; Herlicoviez M; Leymarie P
Br J Obstet Gynaecol; 1996 Apr; 103(4):335-8. PubMed ID: 8605130
[TBL] [Abstract][Full Text] [Related]
48. Second-trimester maternal serum inhibin-A screening for fetal Down syndrome in Asian women.
Lam YH; Tang MH
Prenat Diagn; 1999 May; 19(5):463-7. PubMed ID: 10360516
[TBL] [Abstract][Full Text] [Related]
49. Early detection of preeclampsia using inhibin a and other second-trimester serum markers.
Ree PH; Hahn WB; Chang SW; Jung SH; Kang JH; Cha DH; Kang MS; Huh JY
Fetal Diagn Ther; 2011; 29(4):280-6. PubMed ID: 21252475
[TBL] [Abstract][Full Text] [Related]
50. Dimeric inhibin A as a marker for Down's syndrome in early pregnancy.
Aitken DA; Wallace EM; Crossley JA; Swanston IA; van Pareren Y; van Maarle M; Groome NP; Macri JN; Connor JM
N Engl J Med; 1996 May; 334(19):1231-6. PubMed ID: 8606718
[TBL] [Abstract][Full Text] [Related]
51. Practical strategies in contingent sequential screening for Down syndrome.
Benn P; Wright D; Cuckle H
Prenat Diagn; 2005 Aug; 25(8):645-52. PubMed ID: 16049988
[TBL] [Abstract][Full Text] [Related]
52. Prenatal detection of X-linked ichthyosis by maternal serum screening for Down syndrome.
Bartels I; Caesar J; Sancken U
Prenat Diagn; 1994 Mar; 14(3):227-9. PubMed ID: 8052574
[TBL] [Abstract][Full Text] [Related]
53. Apparently low maternal serum inhibin A levels in second-trimester screening.
Lambert-Messerlian GM; Keren DF; Raphtis CS; Byberg K; Canick JA
Prenat Diagn; 2005 Oct; 25(10):967-8. PubMed ID: 16193465
[No Abstract] [Full Text] [Related]
54. [Screening for Down syndrome using triple marker testing in the second trimester of pregnancy].
Lesin J; Skrablin S; Durić K; Suchanek E; Muzinić D; Kalafatić D; Kuvacić I; Zlopasa G; Plavec A
Lijec Vjesn; 2003; 125(3-4):55-60. PubMed ID: 12899094
[TBL] [Abstract][Full Text] [Related]
55. Second trimester screening for Down's syndrome using maternal serum dimeric inhibin A.
Wallace EM; Swanston IA; McNeilly AS; Ashby JP; Blundell G; Calder AA; Groome NP
Clin Endocrinol (Oxf); 1996 Jan; 44(1):17-21. PubMed ID: 8706288
[TBL] [Abstract][Full Text] [Related]
56. Maternal serum inhibin-A levels in twin pregnancies: implications for screening for Down's syndrome.
Watt HC; Wald NJ; George L
Prenat Diagn; 1996 Oct; 16(10):927-9. PubMed ID: 8938062
[TBL] [Abstract][Full Text] [Related]
57. Maternal serum screening for fetal Down syndrome in women less than 35 years of age using alpha-fetoprotein, hCG, and unconjugated estriol: a prospective 2-year study.
Phillips OP; Elias S; Shulman LP; Andersen RN; Morgan CD; Simpson JL
Obstet Gynecol; 1992 Sep; 80(3 Pt 1):353-8. PubMed ID: 1379701
[TBL] [Abstract][Full Text] [Related]
58. Clinical validation of a new dimeric inhibin-A assay suitable for second trimester Down's syndrome screening.
Knight GJ; Palomaki GE; Neveux LM; Haddow JE; Lambert-Messerlian GM
J Med Screen; 2001; 8(1):2-7. PubMed ID: 11373844
[TBL] [Abstract][Full Text] [Related]
59. Screening for pre-eclampsia by using maternal serum inhibin A, activin A, human chorionic gonadotropin, unconjugated estriol, and alpha-fetoprotein levels and uterine artery Doppler in the second trimester of pregnancy.
Ay E; Kavak ZN; Elter K; Gokaslan H; Pekin T
Aust N Z J Obstet Gynaecol; 2005 Aug; 45(4):283-8. PubMed ID: 16029293
[TBL] [Abstract][Full Text] [Related]
60. Second Trimester Serum Biomarker Screen for Fetal Aneuploidies as a Predictor of Preterm Delivery: A Population-Based Study.
Nunthapiwat S; Sekararithi R; Wanapirak C; Sirichotiyakul S; Tongprasert F; Srisupundit K; Luewan S; Tongsong T
Gynecol Obstet Invest; 2019; 84(4):326-333. PubMed ID: 30602167
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
